Menu Search
Equities

Europlasma SA

0W8R:LSE

Europlasma SA

Actions
  • Price (EUR)0.304
  • Today's Change0.304 / --
  • Shares traded425.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Aug 05 2024 10:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Europlasma SA grew revenues 6.10% from 14.52m to 15.41m while net income improved from a loss of 15.93m to a smaller loss of 14.74m.
Gross margin6.65%
Net profit margin-95.71%
Operating margin-121.54%
Return on assets-29.51%
Return on equity-1,156.85%
Return on investment-68.74%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Europlasma SA fell by 1.26m. Cash Flow from Financing totalled 9.67m or 62.77% of revenues. In addition the company used 9.97m for operations while cash used for investing totalled 953.00k.
Cash flow per share-389.48
Price/Cash flow per share--
Book value per share-65.83
Tangible book value per share-68.36
More ▼

Balance sheet in EURView more

Europlasma SA has a Debt to Total Capital ratio of 170.73%, a higher figure than the previous year's 63.64%.
Current ratio0.4701
Quick ratio0.2169
Total debt/total equity--
Total debt/total capital1.71
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.